A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer.

Authors :: Kaidar-Person O
Dahn HM
Nichol AM
Boersma LJ
de Ruysscher D
Meattini I
Pignol JP
Aristei C
Belkacemi Y
Benjamin D
Bese N
Coles CE
Franco P
Ho AY
Hol S
Jagsi R
Kirby AM
Marrazzo L
Marta GN
Moran MS
Nissen HD
Strnad V
Zissiadis Y
Poortmans PM
Offersen BV
Source :: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Nov; Vol. 164, pp. 115-121. Date of Electronic Publication: 2021 Sep 24.
Publication Year :: 2021
Abstract: Bolus serves as a tissue equivalent material that shifts the 95-100% isodose line towards the skin and subcutaneous tissue. The need for bolus for all breast cancer patients planned for postmastectomy radiation therapy (PMRT) has been questioned. The work was initiated by the faculty of the European SocieTy for Radiotherapy & Oncology (ESTRO) breast cancer courses and represents a multidisciplinary international breast cancer expert collaboration to optimize PMRT. Due to the lack of randomised trials evaluating the benefits of bolus, we designed a stepwise project to evaluate the existing evidence about the use of bolus in the setting of PMRT to achieve an international consensus for the indications of bolus in PMRT, based on the Delphi method.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)

Subjects :: Consensus
Delphi Technique
Female
Humans
Radiotherapy, Adjuvant
Breast Neoplasms radiotherapy
Breast Neoplasms surgery
Mastectomy

Language :: English
ISSN :: 1879-0887
Volume :: 164
Database :: MEDLINE
Journal :: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Publication Type :: Academic Journal
Accession number :: 34563607
Full Text :: https://doi.org/10.1016/j.radonc.2021.09.012

Full Text Access

Tools